GHK‑Copper: Unlocking Cancer‑Fighting Potential
*A naturally occurring tripeptide that reprograms cancer‑related genes while supporting tissue repair.*
GHK‑Copper (also called GHK‑Cu) is a three‑amino‑acid peptide that binds copper with high affinity. Dr. Jason Schuster explains that this combo not only promotes skin, hair, bone and wound healing, but also modulates the expression of genes driving certain cancers, making it a promising anti‑cancer tool.
Tripeptide with Copper Affinity
GHK is a naturally occurring tripeptide composed of glycine (G), histidine (H) and lysine (K). On its own it has a strong affinity for copper ions, creating the GHK‑Copper complex that has been studied for decades in skin‑care, hair loss, nervous tissue, bone, lung and liver health.
Gene Modulation and Vascular Growth
According to Dr. Schuster, GHK‑Copper down‑regulates cancer‑promoting genes and can reverse the expression of about 70 % of the genes in a metastatic colon‑cancer signature. It also raises levels of basic fibroblast growth factor (BFGF) and vascular endothelial growth factor (VEGF), driving new blood‑vessel formation and tissue regeneration.
- High‑affinity copper binding delivers copper’s antibacterial and antiviral effects.
- Suppresses over‑expressed oncogenes in metastatic colon cancer.
- Increases BFGF and VEGF to promote angiogenesis and wound healing.
- Enhances mitochondrial function and ATP production.
Anti‑Cancer and Multi‑Tissue Healing
Dr. Schuster notes that GHK‑Copper has been shown to help hair regrowth, skin rejuvenation, bone healing, and liver rejuvenation, while also exerting anti‑cancer activity through gene reprogramming. Clinical observations suggest it is safe, well‑tolerated and improves cellular environments across many organ systems.
- Reduces hair loss and promotes scalp regeneration.
- Supports skin repair and collagen synthesis.
- Accelerates bone and osteoblastic healing.
- Improves liver tissue appearance in older subjects.
- May aid in controlling certain cancers without stimulating tumor growth.
Topical and Injectable Protocols
Dr. Schuster shares dosing guidance from Dr. Edwin Lee of the Clinical Peptide Society. A topical spray or dropper delivering 5 mg per day is typically used for hair and skin benefits, with results appearing after about three months. For systemic effects, sub‑cutaneous injections of 2.5 mg three times weekly have been reported as safe and effective.
- Topical: 5 mg daily (spray or dropper), 3‑month onset.
- Injectable: 2.5 mg SC three times per week.
- Generally well‑tolerated; monitor for any unexpected reactions.
“GHK reverses the expression of 70 % of the genes in a metastatic colon‑cancer signature, effectively turning down the drivers of the disease.”— Dr. Jason Schuster
Go deeper than the summary
Dr. Schuster's board-certified, accredited peptide therapy courses — the full research, dosing, and video breakdowns.